rxstat › Shortages › Ziprasidone
Ziprasidone shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Ziprasidone products are in shortage in Canada (2 of 8 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
In shortage since
Apr 6, 2026
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.
Reports by product
Active shortageZELDOX
60MG · CAPSULE · BGP PHARMA ULC
DIN 02298619 · since Jun 3, 2026, no end estimate · Disruption of the manufacture of the drug.
Active shortageZELDOX
80MG · CAPSULE · BGP PHARMA ULC
DIN 02298627 · since Apr 6, 2026, no end estimate · Disruption of the manufacture of the drug.
ResolvedAURO-ZIPRASIDONE
40MG · CAPSULE · AURO PHARMA INC
DIN 02449552 · ended Jun 13, 2024 · Demand increase for the drug.
ResolvedAURO-ZIPRASIDONE
20MG · CAPSULE · AURO PHARMA INC
DIN 02449544 · ended Jun 13, 2024 · Demand increase for the drug.
ResolvedAURO-ZIPRASIDONE
20MG · CAPSULE · AURO PHARMA INC
DIN 02449544 · ended Feb 13, 2024 · Demand increase for the drug.
ResolvedZELDOX
60MG · CAPSULE · UPJOHN CANADA ULC
DIN 02298619 · ended Sep 18, 2023 · Disruption of the manufacture of the drug.
ResolvedZELDOX
80MG · CAPSULE · UPJOHN CANADA ULC
DIN 02298627 · ended Aug 8, 2023 · Disruption of the manufacture of the drug.
ResolvedZELDOX
20MG · CAPSULE · UPJOHN CANADA ULC
DIN 02298597 · ended Aug 15, 2023 · Disruption of the manufacture of the drug.
ResolvedAURO-ZIPRASIDONE
20MG · CAPSULE · AURO PHARMA INC
DIN 02449544 · ended Jul 25, 2023 · Demand increase for the drug.
ResolvedAURO-ZIPRASIDONE
80MG · CAPSULE · AURO PHARMA INC
DIN 02449579 · ended Jun 9, 2023 · Demand increase for the drug.
ResolvedZELDOX
20MG · CAPSULE · UPJOHN CANADA ULC
DIN 02298597 · ended Jan 27, 2023 · Disruption of the manufacture of the drug.
ResolvedZELDOX
60MG · CAPSULE · UPJOHN CANADA ULC
DIN 02298619 · ended Jan 9, 2023 · Disruption of the manufacture of the drug.
Showing 12 of 24 reports. All reports are on file with Health Canada.
What's happening
Ziprasidone is currently affected by 2 active shortage reports filed with Health Canada by BGP PHARMA ULC.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Ziprasidone is classified under “ANTIPSYCHOTICS” (ATC N05AE).
Recent changes
Common questions
When will Ziprasidone be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Ziprasidone in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Guides: what to do when your medication is in shortage · how to read shortage reports
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.